Legal Representation
Attorney
Hoang-chi Truong
USPTO Deadlines
Next Deadline
3355 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on renewal date 20150324)
Due Date
March 24, 2035
Grace Period Ends
September 24, 2035
Application History
31 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 8, 2025 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | Loading... |
| Aug 8, 2025 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | Loading... |
| Aug 8, 2025 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | Loading... |
| Aug 6, 2025 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Mar 20, 2025 | E89R | I | TEAS SECTION 8 & 9 RECEIVED | Loading... |
| Mar 24, 2024 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | Loading... |
| Jul 28, 2021 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | Loading... |
| Jul 28, 2021 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | Loading... |
| Jul 27, 2021 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Mar 24, 2021 | E815 | I | TEAS SECTION 8 & 15 RECEIVED | Loading... |
| Mar 24, 2020 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Feb 13, 2018 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 24, 2015 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jan 6, 2015 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 6, 2015 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 17, 2014 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 4, 2014 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Nov 29, 2014 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 20, 2014 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 20, 2014 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 19, 2014 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 28, 2014 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Aug 28, 2014 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 11, 2014 | CEPE | I | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED | Loading... |
| Jun 11, 2014 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jun 11, 2014 | GEAN | O | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | Loading... |
| Jun 11, 2014 | GEAP | F | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | Loading... |
| Jun 11, 2014 | CPEA | R | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | Loading... |
| Jun 10, 2014 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 19, 2014 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 10, 2014 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Custom design and development of chemical reagents and biochemical assays; Development of new technology for others in the field of immunotherapy; DNA analysis services for scientific research purposes; DNA screening for scientific research purposes; Genetic testing for scientific research purposes; Genome amplification; Genotyping services for research or analysis purposes; Laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of immunotherapy; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines
First Use Anywhere:
Sep 8, 2009
First Use in Commerce:
Sep 8, 2009
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOTECHNOLOGIES"